Literature DB >> 30878687

[Diagnosis of pelvic inflammatory disease: Clinical, paraclinical, imaging and laparoscopy criteria. CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines].

A Charvériat1, X Fritel2.   

Abstract

The objective of this literature review is to update the recommendations for clinical practice about the diagnosis of pelvic inflammatory disease (PID), microbiologic diagnosis excluded. An adnexal pain or cervical motion tenderness are the signs that allow a positive diagnosis of PID (LE2). Associated signs (fever, leucorrhoea, metrorrhagia) reinforce clinical diagnosis (LE2). In a woman consulting for symptoms compatible with PID, a pelvic clinical examination is recommended (grade B). In cases of suspected PID, hyperleukocytosis associated with a high C-reactive protein suggests a complicated PID or a differential diagnosis such as acute appendicitis (LE3). The absence of hyperleukocytosis or normal CRP does not rule out the diagnosis of PID (LE1). When PID is suspected, a blood test with a blood count and a CRP test is recommended (grade C). Pelvic ultrasound scan does not contribute to the positive diagnosis of uncomplicated PID because it is insensitive and unspecific (LE3). However, ultrasound scan is recommended to look for signs of complicated PID (polymorphic collection) or differential diagnosis (grade C). Waiting for an ultrasound scan to be performed should not delay the start-up of antibiotic therapy. In case of diagnostic uncertainty, an abdominal-pelvic CT scan with contrast injection is useful for differential diagnosis of urinary, digestive or gynaecological origin (LE2). Laparoscopy is not recommended for the unique purpose of the positive diagnosis of PID (grade B).
Copyright © 2019 CNGOF, SPILF. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Diagnostic; Infection génitale haute; Pelvic inflammatory disease; Sensibilité; Sensitivity; Specificity; Spécificité

Year:  2019        PMID: 30878687     DOI: 10.1016/j.gofs.2019.03.010

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil Senol        ISSN: 2468-7189


  5 in total

1.  Effect of Fu Yan Qing prescription on pelvic effusion, mass absorption and microenvironment of pelvic blood stasis in patients with sequelae of pelvic inflammatory disease of accumulation of dampness heat and blood stasis type.

Authors:  Sujuan Zhang; Lijin Yuan; Yunliang Wang; Zhe Sun
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

2.  A Need for Standardization of the Diagnosis and Treatment of Pelvic Inflammatory Disease: Pilot Study in an Outpatient Clinic in Quito, Ecuador.

Authors:  Francisco Cueva; Andrés Caicedo; Paula Hidalgo
Journal:  Infect Dis Obstet Gynecol       Date:  2020-05-09

Review 3.  Pelvic Pain in Reproductive Age: US Findings.

Authors:  Marco Di Serafino; Francesca Iacobellis; Maria Laura Schillirò; Francesco Verde; Dario Grimaldi; Giuseppina Dell'Aversano Orabona; Martina Caruso; Vittorio Sabatino; Chiara Rinaldo; Vito Cantisani; Gianfranco Vallone; Luigia Romano
Journal:  Diagnostics (Basel)       Date:  2022-04-09

4.  Bioinformatic Characterization of Whole Blood Neutrophils in Pelvic Inflammatory Disease: A Potential Prognostic Indicator for Transumbilical Single-Port Laparoscopic Pelvic Abscess Surgery.

Authors:  Haining Li; Yanling Hu; Dan Liu; Juanjuan Wang; Panpan Han; Nan Zhang; Yan Li
Journal:  Comput Math Methods Med       Date:  2022-04-01       Impact factor: 2.238

5.  Kangfuxiaoyanshuan alleviates uterine inflammation and adhesion via inhibiting NF-κB p65 and TGF-β/MMP-2 signaling pathway in pelvic inflammatory disease rats.

Authors:  Linyuan Fan; Zhaohui Liu; Zhan Zhang; Ting Li; Xiaonan Zong; Huihui Bai
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.